| Literature DB >> 33145362 |
Manrong Yu1, Hui Chen1, Pan Liu1, Mei Yang1, Leqin Zou1, Dingfu Xiao1,2.
Abstract
The antioxidant function and metabolic profiles in mice after dietary supplementation with methionine were investigated. The results showed that methionine supplementation enhanced liver GSH-Px activity and upregulated Gpx1 expression in the liver and SOD1 and Gpx4 expressions in the jejunum. Nrf2/Keap1 is involved in oxidative stress, and the western blotting data exhibited that dietary methionine markedly increased Keap1 abundance, while failed to influence the Nrf2 signal. Metabolomics investigation showed that methionine administration increased 2-hydroxypyridine, salicin, and asparagine and reduced D-Talose, maltose, aminoisobutyric acid, and inosine 5'-monophosphate in the liver, which are widely reported to involve in oxidative stress, lipid metabolism, and nucleotides generation. In conclusion, our study provides insights into antioxidant function and liver metabolic profiles in response to dietary supplementation with methionine.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33145362 PMCID: PMC7596454 DOI: 10.1155/2020/9494528
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
PCR primer sequences: the forward primers (F) and the reverse primers (R) used in this study.
| Gene | Accession no. | Nucleotide sequence of primers (5′–3′) | Size (bp) |
|---|---|---|---|
|
| NM_007393.3 | F:GTCCACCTTCCAGCAGATGT R:GAAAGGGTGTAAAACGCAGC | 117 |
| CAT | XM_006498624.1 | F:AATATCGTGGGTGACCTCAA | 243 |
| ZnCuSOD | NM_011434.1 | F:CCACTGCAGGACCTCATTTT | 216 |
| Gpx1 | NM_008160.6 | F:GGTTCGAGCCCAATTTTACA | 199 |
| Gpx4 | NM_001037741.3 | F:CTCCATGCACGAATTCTCAG | 117 |
| UCP2 | NM_011671.5 | F:TAGTGCGCACCGCAGCC | 126 |
Growth performance after dietary supplementation with methionine. IBD: initial body weight; FBW: final body weight; AFI: average feed intake; ABWG: average body weight gain; F : G: the ratio of feed intake to weight gain.
| Item | IBW | FBW | AFI | ABWG | F : G |
|---|---|---|---|---|---|
| Cont | 22.26 ± 0.37 | 28.27 ± 0.53 | 5.65 ± 0.05 | 0.30 ± 0.01 | 19.36 ± 0.88 |
| Met | 23.24 ± 0.50 | 26.84 ± 0.47 | 5.76 ± 0.02 | 0.27 ± 0.02 | 21.85 ± 1.26 |
GSH-Px, SOD, and CAT activities in the serum and liver after dietary supplementation with methionine. The ∗ means the difference is significant between the two groups (P < 0.05).
| Item | GSH-Px | SOD | CAT |
|---|---|---|---|
| Serum (U/ml) | |||
| Cont | 17.89 ± 1.22 | 116.74 ± 20.48 | 366.52 ± 135.33 |
| Met | 28.95 ± 7.78 | 131.06 ± 12.51 | 216.77 ± 34.27 |
| Liver (U/mgprot) | |||
| Cont | 26.80 ± 2.35 | 2342.63 ± 50.94 | 188.12 ± 15.24 |
| Met | 152.88 ± 30.01∗ | 2398.21 ± 70.69 | 116.08 ± 20.47∗ |
Figure 1The expression of antioxidant genes (CAT, SOD1, Gpx, Gpx4, and UCP2) in the liver, jejunum, and ileum.
Figure 2Western blot: T1R1 and T1R3 of jejunum, ileum, and liver.
Figure 3Metabolites identified from 534 peaks in the chromatograms and PLS-DA score plots.
List of differential metabolites between the control and Met groups.
| ID | Peak | R.T. | Count | Mass | Cont | Met | VIP |
| Fold change |
|---|---|---|---|---|---|---|---|---|---|
| 13 | 2-hydroxypyridine | 6.61 | 29 | 152 | 0.64 | 1.32 | 1.94 | 0.03 | 2.05 |
| 421 | D-Talose | 17.38 | 16 | 235 | 0.25 | 0.00 | 1.92 | 0.04 | 0.00 |
| 662 | Maltose | 24.22 | 17 | 361 | 4.39 | 1.10 | 1.96 | 0.03 | 0.25 |
| 204 | Aminoisobutyric acid | 12.31 | 23 | 174 | 0.11 | 0.04 | 2.04 | 0.04 | 0.36 |
| 597 | Salicin | 22.42 | 29 | 169 | 0.02 | 0.03 | 1.99 | 0.04 | 2.08 |
| 711 | Inosine 5'-monophosphate | 25.87 | 19 | 169 | 0.01 | 0.00 | 1.94 | <0.01 | 0.09 |
| 300 | Asparagine | 14.37 | 19 | 229 | 0.00 | 0.01 | 2.69 | <0.01 | 3980383.06 |